Annapolis Financial Services’s Corbus Pharmaceuticals CRBP Stock Holding History

Annapolis Financial Services’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-23	Closed	-$139	–	383
2023 Q4	$139	Hold	23	–	–	﹤0.01%	460
2023 Q3	$156	Hold	23	–	–	﹤0.01%	478
2023 Q2	$181	Hold	23	–	–	﹤0.01%	480
2023 Q1	$168	Hold	23	–	–	﹤0.01%	443
2022 Q4	$77	Hold	23	–	–	﹤0.01%	431
2022 Q3	$0	Hold	23	–	–	﹤0.01%	515
2022 Q2	$0	Hold	23	–	–	﹤0.01%	453
2022 Q1	$0	Hold	23	–	–	﹤0.01%	467
2021 Q4	$0	Hold	23	–	–	﹤0.01%	471
2021 Q3	$1K	Hold	23	–	–	﹤0.01%	418
2021 Q2	$1K	Hold	23	–	–	﹤0.01%	391
2021 Q1	$1K	Hold	23	–	–	﹤0.01%	384
2020 Q4	$1K	Buy	+23	New	+$860	﹤0.01%	381

Other funds holding CRBP

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Annapolis Financial Services's CRBP Position: Q1 2024 in Review

Annapolis Financial Services sold out of Corbus Pharmaceuticals (CRBP) in Q1 2024, closing a stake of 23 shares — an estimated $139 sold.

Annapolis Financial Services first reported a position in CRBP in Q4 2020 and held it in 13 quarters. The position peaked at $1K in Q3 2021. 82 funds tracked by Wall St. Rank hold CRBP as of Q1 2024.

Annapolis Financial Services reported no remaining Corbus Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Annapolis Financial Services sold 23 Corbus Pharmaceuticals shares in Q1 2024, an estimated $139.
Annapolis Financial Services first reported a position in Corbus Pharmaceuticals in Q4 2020 and held it in 13 quarters.
Annapolis Financial Services's Corbus Pharmaceuticals position peaked at $1K in Q3 2021.
82 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2024.

Based on Annapolis Financial Services's 13F filing for Q1 2024, filed 17 Apr 2024.